NewsNobody trusts Health: 43,000 Spaniards choose to repeat with...

Nobody trusts Health: 43,000 Spaniards choose to repeat with AstraZeneca against their criteria

More than 43,000 Spaniards have turned their back on the vaccination recommendations of the Ministry of Health only 48 after the department headed by Carolina Darias recommended receiving the second dose of Pfizer to those who inoculated the first with AstraZeneca. About 90% of those who had to repeat doses have done so against the recommendation of Health Professionals under 60 years of age who received a first dose of AstraZeneca weeks ago were waiting for Health to establish clear criteria on the second dose , in view of the thrombus-related events associated with the Oxford vaccine. Thrombi that, as confirmed by medical studies carried out so far, are practically non-existent among those who receive the second dose. If the first has not caused problems, the possibility of the second causing them is practically nil.However, last Wednesday, the Ministry of Health finally made its criteria clear: those who are going to receive the second dose after having received the AstraZeneca’s first should choose the Pfizer compound. If they want to repeat the Oxford vaccine on a voluntary basis, they must sign an informed consent regarding the “risks” involved. Risks that experts indicate greater in the case of mixing vaccines, as proposed by Health. The suggestion of using Pfizer collides head-on with the criteria of the vast majority of the scientific community and even the European Medicines Agency (EMA). The prestigious virologist Margarita del Val has also been in favor of not mixing vaccines, the result of the vaccination chaos with AstraZeneca has been devastating for Health:In the 48 hours that elapsed since the Carolina Darias department set its criteria until this Friday, with the latest official data, 43,000 Spaniards have received the second dose – and with it the complete schedule – with the British vaccine. The crowded queues for the option contrary to the recommendation of Health contrasted with the images of empty corridors to receive Pfizer.Total support to AstraZeneca On Wednesday, the day the Interterritorial Commission of the National Health System (CISNS) met again to reiterate its In preference to Pfizer, there were just 800 people on the second dose of AstraZeneca. And despite the campaign of ‘fear’ generated by Health on this compound, on Friday there were already 43,855 people with the complete guideline. The election of AstraZeneca has been overwhelmingly majority. According to the data provided by the communities, nine out of ten vaccinated with AstraZeneca have chosen this compound for the second dose. In Murcia it was 90% and in Galicia 85%. In the provinces of Cádiz and Córdoba it has touched 100%. In the next few weeks, more than two million people who have yet to be vaccinated will have to make that decision about AstraZeneca or Pfizer. Of the almost 5 million inoculated with the British compound, only 4 thrombi have been detected with fatal results.

To swim with sharks! This is how entrepreneurs float in the face of inflation

The most successful entrepreneur, and the one who can swim and fall in love with sharks, is the one who is willing to learn from every moment of his process, points out Luis Arandia.

#Between the lines | COVID-19. The sixth wave is coming and a (new) variant...

It is not possible to declare when the sixth wave will arrive in Mexico, but now, more than ever, it is urgent that virological surveillance be maintained, points out Jonathán Torres.

In the new reality, brands must establish messages of closeness

The diffusion of modifications to the organizational culture in the face of a new scenario will be successful if it is underpinned by transparent, close and reliable communication, considers Mario Maraboto.

Covid-19: The end of the pandemic is in sight, says the WHO

Tedros Adhanom Ghebreyesus highlighted that last week the number of weekly deaths fell to its lowest level since March 2020.

#Between the lines | The (yet) unsolved mystery of COVID-19

Suddenly it seems that there is a battle between specialists from different medical specialties to see who announces the next misfortune, says Jonathán Torres.

More